Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rang in Aktien #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Aktienkurs
$0.01142111
Zuletzt synchronisiert: 2025-03-21
Marktkapitalisierung
$930.66K
Veränderung (1 Tag)
0.18%
Veränderung (1 Jahr)
-69.73%
Land
IE
Handel Ovoca Bio plc (OVXA)

Kategorie

Kursverlauf für Ovoca Bio plc (OVXA)
Höchster Schlusskurs: $0.13 am 2026-03-01

Niedrigster Schlusskurs: $4.81 am 2000-01-01
Kursverlauf der Aktie von Ovoca Bio plc von 2000 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 90.65%
2025 -22.71%
2024 58.96%
2023 -79.87%
2022 -62.94%
2021 34.96%
2020 -11.29%
2019 44.55%
2018 -33.04%
2017 25.95%
2016 48.97%
2015 -41.68%
2014 -1.33%
2013 -28.06%
2012 -48.16%
2011 -36.54%
2010 71.46%
2009 64.06%
2008 -85.81%
2007 31.32%
2006 43.63%
2005 46.40%
2004 -22.28%
2003 10.61%
2002 27.28%
2001 -46.44%
2000 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$509.53 32.99%
US
$991.92 34.63%
NL
$154.28 511.26%
US
$123.40 -5.68%
AU
$708.28 3.70%
CH